* Streamline Health Solutions Inc STRM.OQ STRM.O is
expected
to show a fall in quarterly revenue when it reports results on
April 29 for the period ending January 31 2024
* The Alpharetta Georgia-based company is expected to
report a
18.6% decrease in revenue to $5.489 million from $6.75 million a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
* LSEG's mean analyst estimate for Streamline Health
Solutions
Inc is for a loss of 4 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Streamline
Health
Solutions Inc is $1.25, above its last closing price of $0.34.
This summary was machine generated April 26 at 21:07 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)